VIROPHARMA INC — key financial figures for fiscal year 2012 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2012)

$427.9M

Net Income/Loss (FY2012)

$5.6M

Total Assets (FY2012)

$1.2B

Total Equity (FY2012)

$757.0M

Cash Flows from Operating Activities (FY2012)

$43.0M

Source: VIROPHARMA INC 10-K filing (FY2012). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.